INCY Gets CHMP Nod
Incyte announces positive CHMP opinion for Opzelura cream for moderate atopic dermatitis treatment
INCY Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis